Rivoceranib Mesylate
N-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;methanesulfonic acid
Molecular Identity
Rivoceranib Mesylate
N-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;methanesulfonic acid
PubChem CID: 45139106
2D Structure
Properties
C25H27N5O4S
Molecular Formula
493.60
Molecular Weight
g/mol
493.1784
Exact Mass
Da
153
TPSA
May have limited oral absorption
3
H-Bond Donors
8
H-Bond Acceptors
701
Complexity
SMILES
Canonical SMILES
SMILES: CS(=O)(=O)O.C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4Isomeric SMILES
SMILES: CS(=O)(=O)O.C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4Synonyms(20)
ApatinibApatinib Mesylate1218779-75-9Rivoceranib mesylateYN968D1YN-968D1TK02X14ASJDTXSID801534273-Pyridinecarboxamide, N-(4-(1-cyanocyclopentyl)phenyl)-2-((4-pyridinylmethyl)amino)-, methanesulfonate (1:1)Aitan3-Pyridinecarboxamide, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-, methanesulfonate (1:1)RefChem:930792DTXCID80759183-Pyridinecarboxamide, N-(4-(1-cyanocyclopentyl)phenyl)-2-((4-methyl-3-pyridinyl)amino)-881-162-7
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Rivoceranib Mesylate
Loading drug network...